About Prescribed Sermorelin

What this site is

Prescribed Sermorelin is an independent editorial project that publishes summaries of the peer-reviewed research literature on sermorelin. We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

We approach the literature the way a careful travel writer approaches a route — charting where the signal goes, what each study actually measured, and where the road honestly runs out of pavement. Every quantitative claim on the site is tied to a numbered source on the references page.

About the name

The word "prescribed" in our name is editorial framing, not a service claim. It points to sermorelin's documented prescribing history — formerly FDA-approved as a pediatric growth-hormone-deficiency drug (NDA 020443), withdrawn from the US market in 2008 for commercial rather than safety reasons, and now prepared by compounding pharmacies. It is the provenance register of the literature we read, not an offer of a prescription, a consultation, or a treatment. This site does not and cannot prescribe anything.

How we handle the evidence

We separate what was shown from what is hoped. We attribute adult body-composition and cognition findings to the stabilized analog (tesamorelin) that produced them rather than transferring them to native sermorelin. We state plainly where the data are thin — particularly for long-term adult anti-aging use — and we flag the caveats regulators have raised. We do not recommend doses for any individual. Doses that appear on the sermorelin dosage in the literature page are reported strictly as study parameters: an amount, a population, a route. When in doubt, we mark the limit rather than fill it.